These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25283510)

  • 1. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.
    Kishi T; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):259-68. PubMed ID: 25283510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
    Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
    BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
    Zhong Z; Zhao S; Zhao Y; Xia S
    Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T. Kishi and N. Iwata: Varenicline for smoking cessation in people with schizophrenia: systematic review meta-analysis.
    Evins AE; Hong LE; Kelly DL
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):269-70. PubMed ID: 25377170
    [No Abstract]   [Full Text] [Related]  

  • 14. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
    Wu L; Sun S; He Y; Zeng J
    Int J Environ Res Public Health; 2015 Aug; 12(9):10235-53. PubMed ID: 26308034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
    Agboola SA; Coleman T; McNeill A; Leonardi-Bee J
    Addiction; 2015 Jul; 110(7):1182-93. PubMed ID: 25846123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
    Smith RC; Amiaz R; Si TM; Maayan L; Jin H; Boules S; Sershen H; Li C; Ren J; Liu Y; Youseff M; Lajtha A; Guidotti A; Weiser M; Davis JM
    PLoS One; 2016; 11(1):e0143490. PubMed ID: 26730716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.